A randomised, open-label, parallel group study to compare the pharmacokinetics and pharmacodynamics of NEODIDRO® 0.266 mg vs DIBASE® 25,000 IU oral doses in male and female patients.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516252-17-00

Acronym

CRC2024_01

Enrollment

Registered

2024-12-02

Start date

2025-12-09

Completion date

Unknown

Last updated

2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with low Vitamin D plasma level

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Italy

None listed

Source: EU CTIS · Data processed: Feb 4, 2026